FDA Inspection 1036247 — CSPC Ouyi Pharmaceutical Co., Ltd.
The FDA completed an inspection of CSPC Ouyi Pharmaceutical Co., Ltd. on Oct 20, 2017 in Shijiazhuang. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 20, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shijiazhuang (China)